Back

Beta-blocker dose is associated with mortality after myocardial infarction - a nationwide study

29 August 2017 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 7 - Best Posters in prevention Epidemiology, lipids ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Susanne Bendesgaard Pedersen

Aarhus University Hospital, Aarhus (Denmark)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Miss A. Schuurman (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Doctor A. Boscheri (Munich, DE)
Abstract Slides
Presentation thumbnail
Doctor P. Ueda (Stockholm, SE)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 7 - Best Posters in prevention

The Event

Event poster

ESC Congress 2017

29 August 2017 14:00 CET
You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
17 November 2025
thumbnail
Congress Presentation
Target dose of heart failure medications is associated with better mortality/morbidity: data from the Swedish Heart Failure Registry
29 June 2021
thumbnail
Congress Presentation
Biomarker associated trends in mortality in myocardial infarction as an example of clinical data warehouse analyses - new opportunities of data-driven cardiovascular research
25 August 2023
thumbnail
Congress Presentation
Beta-blocker exposure and long-term survival in patients with transthyretin amyloid cardiomyopathy.
27 August 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources